REFERENCES
- American_Cancer_Society. Cancer Facts and Figures 2007. Atlanta 2007
- Fleming A. J., Jr., Smith S. P., Jr., Paul C. M., Hall N. C., Daly B. T., et al. Impact of [18F]-2-fluorodeoxyglucose-positron emission tomography/computed tomography on previously untreated head and neck cancer patients. Laryngoscope 2007; 117: 1173–1179
- Vokes E. E., Weichselbaum R. R., Lippman S. M., Hong W. K. Head and neck cancer. N Engl J Med 1993; 328: 184–194
- Abiko Y., Saitoh M., Nishimura M., Yamazaki M., Sawamura D., et al. Role of beta-defensins in oral epithelial health and disease. Med Mol Morphol 2007; 40: 179–184
- Kaus A., Jacobsen F., Sorkin M., Rittig A., Voss B., et al. Host defence peptides in human burns. Burns 2008; 34: 32–40
- Hoover D. M., Wu Z., Tucker K., Lu W., Lubkowski J. Antimicrobial characterization of human beta-defensin 3 derivatives. Antimicrob Agents Chemother 2003; 47: 2804–2809
- Harder J., Bartels J., Christophers E., Schroder J. M. Isolation and characterization of human beta -defensin-3, a novel human inducible peptide antibiotic. J Biol Chem 2001; 276: 5707–5713
- Meyer J. E., Harder J. Antimicrobial peptides in oral cancer. Curr Pharm Des 2007; 13: 3119–3130
- Sawaki K., Mizukawa N., Yamaai T., Yoshimoto T., Nakano M., et al. High concentration of beta-defensin-2 in oral squamous cell carcinoma. Anticancer Res 2002; 22: 2103–2107
- Wenghoefer M., Pantelis A., Dommisch H., Reich R., Martini M., et al. Decreased gene expression of human beta-defensin-1 in the development of squamous cell carcinoma of the oral cavity. Int J Oral Maxillofac Surg. 2008
- Dale B. A., Fredericks L. P. Antimicrobial peptides in the oral environment: expression and function in health and disease. Curr Issues Mol Biol 2005; 7: 119–133
- Nishimura M., Abiko Y., Kusano K., Yamazaki M., Saitoh M., et al. Localization of human beta-defensin 3 mRNA in normal oral epithelium, leukoplakia, and lichen planus: an in situ hybridization study. Med Electron Microsc 2003; 36: 94–97
- Abiko Y., Mitamura J., Nishimura M., Muramatsu T., Inoue T., et al. Pattern of expression of beta-defensins in oral squamous cell carcinoma. Cancer Lett 1999; 143: 37–43
- Abiko Y., Suraweera A. K., Nishimura M., Arakawa T., Takuma T., et al. Differential expression of human beta-defensin 2 in keratinized and non-keratinized oral epithelial lesions; immunohistochemistry and in situ hybridization. Virchows Arch 2001; 438: 248–253
- Dommisch H., Acil Y., Dunsche A., Winter J., Jepsen S. Differential gene expression of human beta-defensins (hBD-1, -2, -3) in inflammatory gingival diseases. Oral Microbiol Immunol 2005; 20: 186–190
- Meyer J. E., Harder J., Gorogh T., Weise J. B., Schubert S., et al. Human beta-defensin-2 in oral cancer with opportunistic Candida infection. Anticancer Res 2004; 24: 1025–1030
- Yoshimoto T., Yamaai T., Mizukawa N., Sawaki K., Nakano M., et al. Different expression patterns of beta-defensins in human squamous cell carcinomas. Anticancer Res 2003; 23: 4629–4633